---
title: Study to Compare CAUTI Rates Following ERASE CAUTI Tray Non-Silver vs Silver Coated Foley Catheters
nct_id: NCT02101762
overall_status: TERMINATED
sponsor: Medline Industries
study_type: OBSERVATIONAL
primary_condition: Surgery
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT02101762.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT02101762"
ct_last_update_post_date: 2016-09-13
last_seen_at: "2026-05-12T06:14:31.284Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Study to Compare CAUTI Rates Following ERASE CAUTI Tray Non-Silver vs Silver Coated Foley Catheters

**Official Title:** A Clinical Study to Compare the CAUTI Rates Following ERASE CAUTI Tray Non-Silver Coated Foley Catheters Verse Silver Coated Foley Catheters

**NCT ID:** [NCT02101762](https://clinicaltrials.gov/study/NCT02101762)

## Key Facts

- **Status:** TERMINATED
- **Why Stopped:** Funding
- **Study Type:** OBSERVATIONAL
- **Target Enrollment:** 756
- **Lead Sponsor:** Medline Industries
- **Conditions:** Surgery, Intensive Care Units
- **Start Date:** 2014-05
- **Completion Date:** 2016-09
- **CT.gov Last Update:** 2016-09-13

## Brief Summary

The Foley catheter is one component in a catheter insertion procedure that could contribute to a catheter associated urinary tract infection (CAUTI). Improvement in the catheter insertion procedures using the ERASE CAUTI Tray system may help to lower these infection rates.

## Eligibility

- **Minimum age:** 18 Years
- **Sex:** ALL
- **Healthy Volunteers:** No

```
Inclusion Criteria:

* At least 18 years of age
* Received Either silver coated Foley catheter or ERASE CAUTI non-silver coated catheter

Exclusion Criteria:

* UTI present upon current hospital admission
* Burn patients, transplant patients, or immune-compromised patients.
```

## Arms

- **Silver Coated Catheters** — Subjects that had previously received silver coated Foley catheters.
- **ERASE CAUTI Non-Silver Coated Catheters** — Subjects that received non-silver catheters from an ERASE CAUTI tray.

## Primary Outcomes

- **Change in Urinary tract infection rates** _(time frame: 3-9 months based on size of ICU and catheter usage)_ — Infection rate/1000 catheter days.

## Secondary Outcomes

- **Catheter use** _(time frame: Catheter days)_
- **Infection Costs** _(time frame: Duration of infection)_

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.whyStopped` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `outcomes.secondary` — added _(2026-05-12)_
- `armsInterventions.arms` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT02101762.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT02101762*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*